Menu
GeneBe

6-54343226-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014464.4(TINAG):c.625G>A(p.Ala209Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,549,114 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/25 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 1 hom. )

Consequence

TINAG
NM_014464.4 missense, splice_region

Scores

1
18
Splicing: ADA: 0.0009025
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.416
Variant links:
Genes affected
TINAG (HGNC:14599): (tubulointerstitial nephritis antigen) This gene encodes a glycoprotein that is restricted within the kidney to the basement membranes underlying the epithelium of Bowman's capsule and proximal and distal tubules. Autoantibodies against this protein are found in sera of patients with tubulointerstital nephritis, membranous nephropathy and anti-glomerular basement membrane nephritis. Ontogeny studies suggest that the expression of this antigen is developmentally regulated in a precise spatial and temporal pattern throughout nephrogenesis. [provided by RefSeq, Nov 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.032821447).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TINAGNM_014464.4 linkuse as main transcriptc.625G>A p.Ala209Thr missense_variant, splice_region_variant 5/11 ENST00000259782.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TINAGENST00000259782.9 linkuse as main transcriptc.625G>A p.Ala209Thr missense_variant, splice_region_variant 5/111 NM_014464.4 P1Q9UJW2-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
151922
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000441
AC:
10
AN:
227004
Hom.:
0
AF XY:
0.0000566
AC XY:
7
AN XY:
123606
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000364
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000157
AC:
22
AN:
1397192
Hom.:
1
Cov.:
30
AF XY:
0.0000231
AC XY:
16
AN XY:
693464
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000271
Gnomad4 SAS exome
AF:
0.000259
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.29e-7
Gnomad4 OTH exome
AF:
0.0000175
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151922
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74186
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000494
AC:
6
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 05, 2022The c.625G>A (p.A209T) alteration is located in exon 5 (coding exon 5) of the TINAG gene. This alteration results from a G to A substitution at nucleotide position 625, causing the alanine (A) at amino acid position 209 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
7.4
Dann
Benign
0.40
DEOGEN2
Benign
0.0048
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.55
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.033
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
1.0
D;N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.16
N
REVEL
Benign
0.097
Sift
Benign
0.73
T
Sift4G
Benign
0.58
T
Polyphen
0.090
B
Vest4
0.11
MutPred
0.30
Gain of glycosylation at A209 (P = 0.0029);
MVP
0.20
MPC
0.010
ClinPred
0.022
T
GERP RS
2.0
Varity_R
0.046
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00090
dbscSNV1_RF
Benign
0.19
SpliceAI score (max)
0.40
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.40
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200699663; hg19: chr6-54208024; API